1. Home
  2. PRQR vs TPVG Comparison

PRQR vs TPVG Comparison

Compare PRQR & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • TPVG
  • Stock Information
  • Founded
  • PRQR 2012
  • TPVG 2013
  • Country
  • PRQR Netherlands
  • TPVG United States
  • Employees
  • PRQR N/A
  • TPVG N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • TPVG Other Consumer Services
  • Sector
  • PRQR Health Care
  • TPVG Consumer Discretionary
  • Exchange
  • PRQR Nasdaq
  • TPVG Nasdaq
  • Market Cap
  • PRQR 309.5M
  • TPVG 242.0M
  • IPO Year
  • PRQR 2014
  • TPVG N/A
  • Fundamental
  • Price
  • PRQR $1.55
  • TPVG $6.30
  • Analyst Decision
  • PRQR Strong Buy
  • TPVG Hold
  • Analyst Count
  • PRQR 6
  • TPVG 6
  • Target Price
  • PRQR $9.00
  • TPVG $6.55
  • AVG Volume (30 Days)
  • PRQR 678.2K
  • TPVG 326.1K
  • Earning Date
  • PRQR 05-08-2025
  • TPVG 05-07-2025
  • Dividend Yield
  • PRQR N/A
  • TPVG 19.02%
  • EPS Growth
  • PRQR N/A
  • TPVG N/A
  • EPS
  • PRQR N/A
  • TPVG 0.93
  • Revenue
  • PRQR $21,212,711.00
  • TPVG $101,389,000.00
  • Revenue This Year
  • PRQR $6.44
  • TPVG N/A
  • Revenue Next Year
  • PRQR N/A
  • TPVG $5.01
  • P/E Ratio
  • PRQR N/A
  • TPVG $6.82
  • Revenue Growth
  • PRQR 85.91
  • TPVG N/A
  • 52 Week Low
  • PRQR $1.07
  • TPVG $5.53
  • 52 Week High
  • PRQR $4.62
  • TPVG $9.70
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 50.51
  • TPVG 50.94
  • Support Level
  • PRQR $1.50
  • TPVG $5.87
  • Resistance Level
  • PRQR $2.02
  • TPVG $6.18
  • Average True Range (ATR)
  • PRQR 0.17
  • TPVG 0.18
  • MACD
  • PRQR 0.03
  • TPVG 0.05
  • Stochastic Oscillator
  • PRQR 48.04
  • TPVG 88.33

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

About TPVG TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.

Share on Social Networks: